| Bioactivity | Leramistat (HMC-C-01-A; MBS2320) is a mitochondrial complex 1 inhibitor, involving in cell metabolism immune metabolism regulation.Leramistat inhibits atopic dermatitis and other skin diseases autoimmune diseases, inflammatory diseases, cancer; and also inhibits osteoclast mediated disease[1]. |
| Target | mitochondrial complex 1 |
| Name | Leramistat |
| CAS | 1642602-54-7 |
| Formula | C20H21ClN2O3S |
| Molar Mass | 404.91 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Patel, et al. Preparation of N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use. World Intellectual Property Organization, WO2014207445 A1 2014-12-31. |
Leramistat
CAS: 1642602-54-7 F: C20H21ClN2O3S W: 404.91
Leramistat (HMC-C-01-A; MBS2320) is a mitochondrial complex 1 inhibitor, involving in cell metabolism immune metabolism
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.